These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 32213711)
61. Hepatocyte-Specific Deletion of AMPKα1 Results in Worse Outcomes in Mice Subjected to Sepsis in a Sex-Specific Manner. Kikuchi S; Piraino G; O'Connor M; Wolfe V; Ridings K; Lahni P; Zingarelli B Front Immunol; 2020; 11():210. PubMed ID: 32117320 [TBL] [Abstract][Full Text] [Related]
62. Aberrant role of pyruvate kinase M2 in the regulation of gamma-secretase and memory deficits in Alzheimer's disease. Han J; Hyun J; Park J; Jung S; Oh Y; Kim Y; Ryu SH; Kim SH; Jeong EI; Jo DG; Park SH; Jung YK Cell Rep; 2021 Dec; 37(10):110102. PubMed ID: 34879266 [TBL] [Abstract][Full Text] [Related]
63. Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology. Stygelbout V; Leroy K; Pouillon V; Ando K; D'Amico E; Jia Y; Luo HR; Duyckaerts C; Erneux C; Schurmans S; Brion JP Brain; 2014 Feb; 137(Pt 2):537-52. PubMed ID: 24401760 [TBL] [Abstract][Full Text] [Related]
64. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway. Liu B; Liu J; Wang JG; Liu CL; Yan HJ Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713 [TBL] [Abstract][Full Text] [Related]
65. AMP-activated protein kinase: a potential player in Alzheimer's disease. Salminen A; Kaarniranta K; Haapasalo A; Soininen H; Hiltunen M J Neurochem; 2011 Aug; 118(4):460-74. PubMed ID: 21623793 [TBL] [Abstract][Full Text] [Related]
67. p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer's disease. Li JB; Hu XY; Chen MW; Xiong CH; Zhao N; Ge YH; Wang H; Gao XL; Xu NJ; Zhao LX; Yu ZH; Chen HZ; Qiu Y Transl Neurodegener; 2023 Jan; 12(1):1. PubMed ID: 36624510 [TBL] [Abstract][Full Text] [Related]
68. Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease. Monteiro-Cardoso VF; Oliveira MM; Melo T; Domingues MR; Moreira PI; Ferreiro E; Peixoto F; Videira RA J Alzheimers Dis; 2015; 43(4):1375-92. PubMed ID: 25182746 [TBL] [Abstract][Full Text] [Related]
69. Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model. Li W; Yu J; Liu Y; Huang X; Abumaria N; Zhu Y; Huang X; Xiong W; Ren C; Liu XG; Chui D; Liu G J Neurosci; 2013 May; 33(19):8423-41. PubMed ID: 23658180 [TBL] [Abstract][Full Text] [Related]
70. Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology. Xiang Z; Ho L; Valdellon J; Borchelt D; Kelley K; Spielman L; Aisen PS; Pasinetti GM Neurobiol Aging; 2002; 23(3):327-34. PubMed ID: 11959394 [TBL] [Abstract][Full Text] [Related]
71. Curcumin alleviates Alzheimer's disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway. Shao S; Ye X; Su W; Wang Y J Chem Neuroanat; 2023 Dec; 134():102363. PubMed ID: 37989445 [TBL] [Abstract][Full Text] [Related]
72. Microsomal prostaglandin E synthase-1 is induced in alzheimer's disease and its deletion mitigates alzheimer's disease-like pathology in a mouse model. Akitake Y; Nakatani Y; Kamei D; Hosokawa M; Akatsu H; Uematsu S; Akira S; Kudo I; Hara S; Takahashi M J Neurosci Res; 2013 Jul; 91(7):909-19. PubMed ID: 23553915 [TBL] [Abstract][Full Text] [Related]
73. Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease. Yang W; Zhou X; Zimmermann HR; Cavener DR; Klann E; Ma T Neurobiol Aging; 2016 May; 41():19-24. PubMed ID: 27103515 [TBL] [Abstract][Full Text] [Related]
74. Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target. Syeda T; Cannon JR J Biochem Mol Toxicol; 2021 Apr; 35(4):e22694. PubMed ID: 33393683 [TBL] [Abstract][Full Text] [Related]
75. Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's Disease. Majd S; Power JHT Curr Alzheimer Res; 2018; 15(8):764-776. PubMed ID: 29473507 [TBL] [Abstract][Full Text] [Related]
76. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques. Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919 [TBL] [Abstract][Full Text] [Related]
77. Chronic Hypoxia-Induced Autophagy Aggravates the Neuropathology of Alzheimer's Disease through AMPK-mTOR Signaling in the APPSwe/PS1dE9 Mouse Model. Liu H; Qiu H; Xiao Q; Le W J Alzheimers Dis; 2015; 48(4):1019-32. PubMed ID: 26444766 [TBL] [Abstract][Full Text] [Related]
78. Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease. Lee HT; Lee KI; Chen CH; Lee TS J Neuroinflammation; 2019 Dec; 16(1):267. PubMed ID: 31847859 [TBL] [Abstract][Full Text] [Related]
79. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease. Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400 [TBL] [Abstract][Full Text] [Related]
80. Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKalpha. Qiang W; Weiqiang K; Qing Z; Pengju Z; Yi L Exp Mol Med; 2007 Aug; 39(4):535-43. PubMed ID: 17934342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]